Collaboration to advance manufacturing of regenerative medicine and biotherapeutics
A collaboration between Mayo Clinic and National Resilience Inc. hopes to advance the biomanufacturing and delivery of novel biologic therapeutics for rare and complex conditions.
Mayo Clinic have announced a strategic collaboration with National Resilience Inc. in Rochester, Minnesota for the biomanufacturing of novel biotherapeutics for rare and complex conditions, centring Rochester as a hub for regenerative medicine manufacturing.
The collaboration hopes to focus on biologic therapies by bringing together innovative science and engineering for the manufacturing of therapies utilizing cells, blood, enzymes, tissues, genes, and genetically engineered cells. Biologics encompass any range of therapeutics that are isolated from biological sources, whether all or partially synthesized. Such therapies include vaccines, blood and blood components, allergenics, cell and gene therapies, and recombinant therapeutic proteins. Julie Allickson, Director of Mayo Clinic’s Center for Regenerative Medicine, commented: “This nexus of entrepreneurs, start-ups, and industry experts will help position Mayo Clinic as an authority in regenerative biotherapeutics.”
National Resilience and Mayo Clinic hope to collaborate and focus on the advancement of Mayo Clinic biotherapeutics with expertise in process development, the attraction of biotech companies for clinical trial sponsorship, providing cell and gene therapy products required for early-stage therapeutics biomanufacturing and analytical testing and quality control for manufacturing commercial-grade biopharmaceuticals. All areas of focus are committed to the advancement of biomanufacturing in new biologic-based medicines in hopes of accelerating clinical care options for patients of rare and complex conditions, which the collaboration hopes to provide.
Kinney Executive Dean of Research at Mayo Clinic Gregory Gores stated: “Mayo Clinic will advance regenerative technologies from discovery science to early phase clinical trials… Research in the emerging field of biotherapeutics lays the foundation to attract the scientific workforce of the future.”
Related News
-
News Pharmapack Awards 2024 Patient-Centric Design Award Winner – Dr Ferrer BioPharma
The 2024 Pharmapack Awards celebrated the best in innovation and design for the pharmaceutical packaging and drug delivery industry on January 24, 2024. -
News Women in Pharma: Minding the Gap at Pharmapack 2024
2024 marks the first year Pharmapack will host a Diversity track dedicated to bridging the gap within the pharmaceutical packaging and drug delivery sector. The track includes a panel discussion on 'Enabling Diversity in the Workplace,' focused... -
News Pharmapack Awards 2024 - Celebrating Packaging and Drug Delivery Innovation
The 2024 Pharmapack Innovation Awards ceremony celebrated the best in pharmaceutical packaging and drug delivery innovation at all levels. The awards were held on January 24, 2024 at the Paris Expo Porte de Versailles. -
News 2024 Pharma Industry Trends Outlook: Collaboration, Market Maturity, and Digital Futures
The annual CPHI Online 2024 Pharma Trends Outlook, in partnership with Arvato Systems, identifies 12 key industry trends shaping the life sciences industry in the coming year. -
News New Novo Nordisk AI hub for drug discovery to open in London, UK
Danish pharmaceutical giant Novo Nordisk will be opening an AI-based research facility in the heart of London to advance drug discovery operations. -
News BioNTech to begin mRNA vaccine manufacturing in Rwanda by 2025
German biotechnology company BioNTech has stated their intentions to begin production at their mRNA vaccine factory in Rwanda by 2025, which will mark the first foreign mRNA vaccine manufacturing site on the continent of Africa. -
News Women in Pharma: Looking back on 2023 and moving forward to 2024
In this monthly series, we interview women from across the pharmaceutical industry and supply chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond. -
News CPHI Barcelona 2023: Partnering for Success – Managing Outsourcing Relationships to Optimise Manufacturing Operations
During CPHI Barcelona 2023, insightful content sessions offered attendees the chance to explore trending topics with expert speakers and panellists. Here, we summarise what the pharma industry and supply chain are talking about the most.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance